Study design, participants and treatment
HAE, neutropenia, leukopenia, anemia, lymphopenia
ADVERSE EVENT, NEUTROPENIA, THROMBOPENIA, LEUKOPENIA, ADVERSE EVENTS, ANEMIA, LYMPHOPENIA
The CeTeG/NOA-09 study design has been published previously [HAE were defined as thrombopenia, leukopenia, lymphopenia, neutropenia, or anemia of grade 3 or higher. All adverse events were rated according to the Common Terminology of Clinical Adverse Events (CTCAE) version 4.0 and documented using pre-specified clinical reporting forms.